Turning to "Omics" in Understanding Fontan-Associated Liver Disease

Affiliations

¹ Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Electronic address: Yuli.Kim@pennmedicine.upenn.edu.
² Division of Gastroenterology and Hepatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Free article

Editorial

Yuli Y Kim et al. J Am Coll Cardiol. 2024.

Free article

. 2024 Feb 20;83(7):739-740.

doi: 10.1016/j.jacc.2023.12.025.

¹ Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Electronic address: Yuli.Kim@pennmedicine.upenn.edu.
² Division of Gastroenterology and Hepatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

No abstract available

Keywords: Fontan outcomes; Fontan-associated liver disease; liver fibrosis; single ventricle; transcriptomics.

Conflict of interest statement

Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation.
Bravo-Jaimes K, Wu X, Reardon LC, Lluri G, Lin JP, Moore JP, van Arsdell G, Biniwale R, Si MS, Naini BV, Venick R, Saab S, Wray CL, Ponder R, Rosenthal C, Klomhaus A, Böstrom KI, Aboulhosn JA, Kaldas FM. Bravo-Jaimes K, et al. J Am Coll Cardiol. 2024 Feb 20;83(7):726-738. doi: 10.1016/j.jacc.2023.12.005. J Am Coll Cardiol. 2024. PMID: 38355242 Free PMC article.